Devendra Amin, MD
Pulmonary Disease · Clearwater, FLNPI 1508847070
Payments from drug & device makers
Across 50 payments — averaging $2585.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomerieux Inc$125K
- Fisher Scientific Company L.L.C.$3K
- BD$787
- Mallinckrodt Hospital Products Inc.$149
- Exthera Medical Corporation$138
- Johnson & Johnson$83
- plus $163 from 3 others
What the payments were for
- Consulting fees$6001%
- Speaking & faculty fees$38,27567%
- Travel & lodging$17,32630%
- Food & beverage$1,1752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomerieux Inc | 34 | $125,381 |
| Fisher Scientific Company L.L.C. | 2 | $2,575 |
| BD | 3 | $787 |
| Mallinckrodt Hospital Products Inc. | 1 | $149 |
| Exthera Medical Corporation | 2 | $138 |
| Johnson & Johnson | 5 | $83 |
| Insmed, Inc. | 1 | $74 |
| Medtronic | 1 | $69 |
| Bayer | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIDAS NEPHROCHECK$23,471
- VIDAS BRAHMS PCT$20,018
- FILMARRAY PNEUMONIA PANEL (PNEUMO)$8,866
- Procalcitonin$2,500
- TERLIVAZ$149
How this compares
$129,276 in reported general payments places this provider in the 85th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Clearwater
- Francis AverillClearwater$6.3M
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
- Carlos MartinezHomestead$9.2M
- Leonard DunnDunedin$7.6M
- Charles BurgerJacksonville$5.6M
- Daniel LorchBrandon$5.5M
- Lourdes BoschMiami$4.2M
- Raj KarunakaraOcala$4M
- Neal WarshoffLoxahatchee$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.